Roos Van Elzen

560 total citations
23 papers, 450 citations indexed

About

Roos Van Elzen is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Roos Van Elzen has authored 23 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Roos Van Elzen's work include Peptidase Inhibition and Analysis (13 papers), Neuropeptides and Animal Physiology (9 papers) and Signaling Pathways in Disease (5 papers). Roos Van Elzen is often cited by papers focused on Peptidase Inhibition and Analysis (13 papers), Neuropeptides and Animal Physiology (9 papers) and Signaling Pathways in Disease (5 papers). Roos Van Elzen collaborates with scholars based in Belgium, United Kingdom and Estonia. Roos Van Elzen's co-authors include Anne‐Marie Lambeir, Pieter Van der Veken, Christian Johannessen, Frank Sobott, Melanie Gérard, Albert Konijnenberg, Carl Mensch, Veerle Baekelandt, Ingrid De Meester and Timo T. Myöhänen and has published in prestigious journals such as Biochemistry, Scientific Reports and Journal of Cell Science.

In The Last Decade

Roos Van Elzen

23 papers receiving 447 citations

Peers

Roos Van Elzen
Henry C.-H. Law United States
Pranab Maiti United States
Michael Gandy United Kingdom
Matthew Mahoney United States
Anup D. Shah Australia
Christopher K. Arnatt United States
Roos Van Elzen
Citations per year, relative to Roos Van Elzen Roos Van Elzen (= 1×) peers Antonio Limatola

Countries citing papers authored by Roos Van Elzen

Since Specialization
Citations

This map shows the geographic impact of Roos Van Elzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roos Van Elzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roos Van Elzen more than expected).

Fields of papers citing papers by Roos Van Elzen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roos Van Elzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roos Van Elzen. The network helps show where Roos Van Elzen may publish in the future.

Co-authorship network of co-authors of Roos Van Elzen

This figure shows the co-authorship network connecting the top 25 collaborators of Roos Van Elzen. A scholar is included among the top collaborators of Roos Van Elzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roos Van Elzen. Roos Van Elzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elzen, Roos Van, Yannick Waumans, Sangeeta Nath, et al.. (2025). The prolyl oligopeptidase and α-synuclein connection revisited. Biochimie. 233. 1–13. 1 indexed citations
2.
Tanç, Muhammet, Roos Van Elzen, An Bracke, et al.. (2021). In Vitro and In Situ Activity-Based Labeling of Fibroblast Activation Protein with UAMC1110-Derived Probes. Frontiers in Chemistry. 9. 640566–640566. 17 indexed citations
3.
Moons, Rani, Albert Konijnenberg, Carl Mensch, et al.. (2020). Metal ions shape α-synuclein. Scientific Reports. 10(1). 16293–16293. 68 indexed citations
4.
Bracke, An, Roos Van Elzen, Pieter Van der Veken, et al.. (2019). The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma. Clinica Chimica Acta. 495. 154–160. 16 indexed citations
5.
Baatsen, Pieter, Roos Van Elzen, Anne‐Marie Lambeir, et al.. (2018). Vibrational Circular Dichroism Sheds New Light on the Competitive Effects of Crowding and β-Synuclein on the Fibrillation Process of α-Synuclein. Biochemistry. 57(41). 5989–5995. 12 indexed citations
7.
Tsirigotaki, Alexandra, Roos Van Elzen, Pieter Van der Veken, Anne‐Marie Lambeir, & Anastassios Economou. (2017). Dynamics and ligand-induced conformational changes in human prolyl oligopeptidase analyzed by hydrogen/deuterium exchange mass spectrometry. Scientific Reports. 7(1). 2456–2456. 20 indexed citations
8.
Rea, Dean, Roos Van Elzen, Hans De Winter, et al.. (2017). Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling. European Journal of Medicinal Chemistry. 139. 482–491. 16 indexed citations
9.
Mensch, Carl, Albert Konijnenberg, Roos Van Elzen, et al.. (2017). Raman optical activity of human α‐synuclein in intrinsically disordered, micelle‐bound α‐helical, molten globule and oligomeric β‐sheet state. Journal of Raman Spectroscopy. 48(7). 910–918. 33 indexed citations
10.
Elzen, Roos Van, et al.. (2016). Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1864(11). 1481–1488. 21 indexed citations
11.
Elzen, Roos Van, et al.. (2016). Ligand-induced conformational changes in prolyl oligopeptidase: a kinetic approach. Protein Engineering Design and Selection. 30(3). 217–224. 11 indexed citations
12.
Myöhänen, Timo T., Roos Van Elzen, Melanie Gérard, et al.. (2012). A prolyl oligopeptidase inhibitor, KYP‐2047, reduces α‐synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. British Journal of Pharmacology. 166(3). 1097–1113. 94 indexed citations
13.
Veken, Pieter Van der, Vilmos Fülöp, Dean Rea, et al.. (2012). P2-SubstitutedN-Acylprolylpyrrolidine Inhibitors of Prolyl Oligopeptidase: Biochemical Evaluation, Binding Mode Determination, and Assessment in a Cellular Model of Synucleinopathy. Journal of Medicinal Chemistry. 55(22). 9856–9867. 26 indexed citations
14.
Delesalle, Cathérine, et al.. (2011). Morphological data indicate a stress response at the oral border of strangulated small intestine in horses. Research in Veterinary Science. 91(2). 294–300. 8 indexed citations
15.
Elzen, Roos Van & Anne‐Marie Lambeir. (2011). Structure and Function Relationship in Prolyl Oligopeptidase. CNS & Neurological Disorders - Drug Targets. 10(3). 297–305. 18 indexed citations
17.
Jain, Rajeev, Külli Jaako, Roos Van Elzen, et al.. (2011). In situ prolyl oligopeptidase activity assay in neural cell cultures. Journal of Neuroscience Methods. 204(1). 104–110. 5 indexed citations
18.
Elzen, Roos Van, Bart Ghesquière, Evy Timmerman, et al.. (2009). Integrated Proteomic Analysis Reveals a Substantial Enrichment of Protein Trafficking Processes in Hippocampus Tissue after Hypoxic Stress. Journal of Proteome Research. 9(1). 204–215. 4 indexed citations
19.
Gilany, Kambiz, Roos Van Elzen, E. Coen, et al.. (2008). The proteome of the human neuroblastoma cell line SH-SY5Y: An enlarged proteome. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1784(7-8). 983–985. 30 indexed citations
20.
Elzen, Roos Van, Luc Moëns, & Sylvia Dewilde. (2008). Expression profiling of the cerebral ischemic and hypoxic response. Expert Review of Proteomics. 5(2). 263–282. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026